healthcare innovation – The Milli Chronicle

Saturday, December 13, 2025

Latest:

Saudi Arabia Strengthens Local Pharma Innovation with Riyadh Generic Drugs Conference 2025
Saudi Arabia Rises in Global Universal Health Coverage Index with Strong Vision 2030 Reforms
Global Harmony Takes Center Stage as China’s Chorus Choir Debuts in Saudi Arabia
Lululemon CEO exit sparks optimism for brand reset and renewed growth
US regulator grants initial approval for major crypto firms to launch national trust banks

Factual Version of a Story

Featured News World

NewsDesk Milli Chronicle December 11, 2025 aging population health, AI in healthcare, chronic disease diagnostics, CT scans, diagnostic imaging, healthcare expansion, healthcare innovation, healthcare investments, healthcare technology, imaging centers, imaging technology, investor confidence, Lumexa Imaging, medical imaging market, medical services demand, MRI services, Nasdaq IPO, radiology growth, U.S. healthcare trends, U.S. IPO market

Lumexa Imaging makes confident Nasdaq debut with $1.76 billion valuation

Strong investor interest and rising demand for advanced diagnostic imaging push Lumexa Imaging into the spotlight as one of the

Featured News World

NewsDesk Milli Chronicle November 8, 2025November 8, 2025 antitrust regulations, biopharma growth, Eli Lilly competition, healthcare innovation, metabolic health market, Metsera deal, Metsera shareholder meeting, Novo Nordisk withdrawal, obesity drug market, obesity treatment innovation, Pfizer $10 billion merger, Pfizer acquisition, Pfizer strategic expansion., pharmaceutical investments, U.S. biotech mergers, weight-loss drug development

Pfizer secures $10 billion Metsera deal after Novo Nordisk withdraws

Pfizer’s $10 billion acquisition of Metsera marks a major victory for the U.S. pharmaceutical giant, strengthening its position in the

Featured News World

NewsDesk Milli Chronicle October 26, 2025October 26, 2025 biopharma investment, biotechnology news, genetic medicine, healthcare innovation, neuromuscular disorder therapy, Novartis acquisition 2025, Novartis Avidity Biosciences deal, Novartis expansion, pharmaceutical mergers 2025, precision medicine, rare disease treatment, rare muscle disease research., RNA therapeutics, Spinco launch, U.S. biotech growth

Novartis Strengthens Rare Disease Focus with $12 Billion Avidity Biosciences Deal

In a landmark move to advance treatments for rare muscle disorders, Novartis takes a major step toward expanding its innovation

Featured News World

NewsDesk Milli Chronicle October 14, 2025October 14, 2025 CMS star ratings, healthcare innovation, healthcare quality improvement, Humana future strategy, Humana health insurance, Humana Medicare Advantage 2025, Humana patient care, Medicare Advantage providers, senior healthcare plans, U.S. healthcare news

Humana Reaffirms Commitment to Quality Care and Service Excellence Despite Medicare Ruling

Following a U.S. court’s decision upholding the 2025 Medicare Advantage ratings, Humana renews its focus on improving patient care, service

Latest News World

NewsDesk Milli Chronicle October 12, 2025 affordable medicine, Bill Gates, diabetes prevention, Gates Foundation, global health equity, global obesity solutions, healthcare innovation, inclusive healthcare access, low-cost drugs, Mounjaro, obesity in developing countries, PAHO, pharmaceutical partnerships, public health initiatives, semaglutide generics, sustainable healthcare development., Wegovy, weight-loss drugs, WHO obesity report

Bill Gates and PAHO Explore Affordable Access to Weight-Loss Drugs for Developing Nations

London – In a move that could reshape global health access, philanthropist Bill Gates and the Pan American Health Organization

Featured Health Lifestyle

NewsDesk Milli Chronicle October 10, 2025 biotech mergers 2025, biotechnology acquisition, drug development news, global biotech investments, healthcare innovation, J&J biotech expansion, J&J pharma growth, Janssen Biotech collaboration, Johnson & Johnson acquisition, Johnson & Johnson news, Johnson & Johnson strategy., medical research, peptide-based drugs, pharmaceutical innovation, polycythemia vera treatment, Protagonist stock surge, Protagonist Therapeutics, rare disease therapy, Rusfertide PTG-300, WSJ report

Johnson & Johnson Eyes Major Leap in Biotech: Talks Underway to Acquire Protagonist Therapeutics in Billion-Dollar Move

In a bold bid to expand its cutting-edge drug pipeline, Johnson & Johnson is reportedly in advanced talks to acquire

Featured Health Lifestyle

NewsDesk Milli Chronicle October 9, 2025October 9, 2025 $5.2 billion deal, Akero Therapeutics, Akero Therapeutics stock, and future of liver disease treatment., biopharma deal 2025, biotech acquisition, biotech investment, biotech partnership, biotechnology news 2025, cardiometabolic health, clinical trial success, Denmark pharmaceutical industry, drug approval process, drug pipeline expansion, Efruxifermin, efruxifermin clinical trials, Eli Lilly competition, GLP-1 drug development, healthcare innovation, healthcare investment news, late-stage drug trials, liver disease drug, liver disease research, liver scarring reversal, MASH drug approval, MASH treatment, metabolic disease therapy, metabolic dysfunction-associated steatohepatitis, Mike Doustdar, Novo Nordisk, Novo Nordisk acquisition, Novo Nordisk CEO, Novo Nordisk global expansion, Novo Nordisk growth strategy, Novo Nordisk strategic acquisition, obesity and diabetes drugs, pharma R&D deal, pharmaceutical industry update, pharmaceutical innovation, pharmaceutical merger, pharmaceutical research and development, Wegovy manufacturer

Novo Nordisk Makes Bold $5.2 Billion Move with Akero Buyout to Accelerate Liver Disease Breakthroughs

In a landmark deal marking a new era under CEO Mike Doustdar, Novo Nordisk acquires Akero Therapeutics for up to

Latest Middle East and North Africa News

NewsDesk Milli Chronicle October 9, 2025 advanced medical technologies, AI in healthcare, biotech research Saudi Arabia, biotechnology partnerships Saudi Arabia, digital health solutions, Global Health Exhibition 2025, global healthcare hub, health tourism Saudi Arabia, healthcare industry growth, healthcare innovation, healthcare sector expansion, international healthcare investment, medical innovation partnerships, medical technology collaboration, medical technology investment, pharmaceutical collaborations, pharmaceutical industry Saudi Arabia, Riyadh healthcare event, Saudi Arabia healthcare ecosystem, Saudi biotech industry, Saudi healthcare sector, Saudi investment opportunities, Saudi Ministry of Health, Saudi pharmaceutical sector., Saudi private sector healthcare, vaccine production Saudi Arabia, Vision 2030 healthcare, Vision 2030 initiatives

Saudi Arabia to Unveil Major Biotech and Pharmaceutical Partnerships at Global Health Exhibition 2025

Riyadh – Saudi Arabia’s healthcare sector is poised for another wave of growth and innovation, as new biotechnology and pharmaceutical

Featured Health Lifestyle

NewsDesk Milli Chronicle September 25, 2025September 25, 2025 Dutch technology company, global healthcare technology, healthcare compliance, healthcare innovation, healthcare solutions, healthcare technology leader, industrial machinery, infusion pumps, international healthcare innovation, med-tech industry, medical device regulations, medical devices, medical equipment import, medical tech imports, medical technology, medical technology innovation, national security investigation, personal protective equipment, Philips, Philips collaboration, Philips global operations, Philips news, Philips press release, Philips proactive approach, Philips shares, Philips stock update, Philips strategic engagement, Philips US talks, robotics, Section 232, supply chain compliance, syringes, U.S. Department of Commerce, U.S. imports

Philips in talks with US over probes of medical technology imports

“At this stage, details are limited, and a range of potential outcomes remain under discussion,” said Philips in a statement,